Manuel Fuentes-Salgado, Manuel Gardea-Resendez, Andrew Smith, Angie Lam, Kimberly Allen, Mete Ercis, Ashley Kremin, Jeremiah B Joyce, Jin Hong Park, Nicola Keeth, Katherine Moore, Hannah Betcher, Padao Yang, Jonathan G Leung, Aysegul Ozerdem, Samuel T Savitz, Mark D Williams, Victor M Montori, Pollock Michael, Mark A Frye
{"title":"开发一个决策支持工具来指导双相抑郁症治疗的共同决策:临床医生和有生活经验的人之间合作的结果。","authors":"Manuel Fuentes-Salgado, Manuel Gardea-Resendez, Andrew Smith, Angie Lam, Kimberly Allen, Mete Ercis, Ashley Kremin, Jeremiah B Joyce, Jin Hong Park, Nicola Keeth, Katherine Moore, Hannah Betcher, Padao Yang, Jonathan G Leung, Aysegul Ozerdem, Samuel T Savitz, Mark D Williams, Victor M Montori, Pollock Michael, Mark A Frye","doi":"10.1111/bdi.70037","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To build consensus from different stakeholders on the content and digital interactivity of a shared decision making (SDM) tool to guide patient-clinician collaborative conversations about treatment for bipolar depression.</p><p><strong>Patients and methods: </strong>This study was conducted between September 2022 and September 2023. In the first phase, we conducted a narrative review on pharmacological, neuromodulatory, and psychotherapeutic treatments available for bipolar depression. For each option, we assessed treatment effectiveness, side effects, need for clinical monitoring, clinical considerations, and cost. In the second phase, committees comprised of mental health clinicians and people with lived experience with bipolar disorder from a national mood disorders advocacy group identified key features and content to be included in the SDM tool. A thematic analysis of these data then contributed to populate the SDM tool.</p><p><strong>Results: </strong>Twenty-one evidence-based treatment options identified from the narrative review were presented to the four convened committees (clinical, lived experience, peer council, and integrated steering committees) in five meetings. After discussions and thematic analysis, 12 outcomes of interest for each of the therapeutic interventions were delineated for inclusion in a web-based SDM tool. A detailed description of the development process and SDM tool is provided.</p><p><strong>Conclusion: </strong>This is the first partnership between clinicians and persons with bipolar disorder lived experience charged with the development of a patient-centered SDM tool to integrate clinical evidence with real-world clinical practice and patient preferences for use during clinical encounters. Human-centered design and testing in real clinical encounters will now contribute to refining the instrument and readying it for rigorous evaluation and implementation in practice.</p>","PeriodicalId":8959,"journal":{"name":"Bipolar Disorders","volume":" ","pages":""},"PeriodicalIF":5.0000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Developing a Decision Support Tool to Guide Shared Decision-Making in Bipolar Depression Treatment: Results From a Collaboration Between Clinicians and People With Lived Experience.\",\"authors\":\"Manuel Fuentes-Salgado, Manuel Gardea-Resendez, Andrew Smith, Angie Lam, Kimberly Allen, Mete Ercis, Ashley Kremin, Jeremiah B Joyce, Jin Hong Park, Nicola Keeth, Katherine Moore, Hannah Betcher, Padao Yang, Jonathan G Leung, Aysegul Ozerdem, Samuel T Savitz, Mark D Williams, Victor M Montori, Pollock Michael, Mark A Frye\",\"doi\":\"10.1111/bdi.70037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To build consensus from different stakeholders on the content and digital interactivity of a shared decision making (SDM) tool to guide patient-clinician collaborative conversations about treatment for bipolar depression.</p><p><strong>Patients and methods: </strong>This study was conducted between September 2022 and September 2023. In the first phase, we conducted a narrative review on pharmacological, neuromodulatory, and psychotherapeutic treatments available for bipolar depression. For each option, we assessed treatment effectiveness, side effects, need for clinical monitoring, clinical considerations, and cost. In the second phase, committees comprised of mental health clinicians and people with lived experience with bipolar disorder from a national mood disorders advocacy group identified key features and content to be included in the SDM tool. A thematic analysis of these data then contributed to populate the SDM tool.</p><p><strong>Results: </strong>Twenty-one evidence-based treatment options identified from the narrative review were presented to the four convened committees (clinical, lived experience, peer council, and integrated steering committees) in five meetings. After discussions and thematic analysis, 12 outcomes of interest for each of the therapeutic interventions were delineated for inclusion in a web-based SDM tool. A detailed description of the development process and SDM tool is provided.</p><p><strong>Conclusion: </strong>This is the first partnership between clinicians and persons with bipolar disorder lived experience charged with the development of a patient-centered SDM tool to integrate clinical evidence with real-world clinical practice and patient preferences for use during clinical encounters. Human-centered design and testing in real clinical encounters will now contribute to refining the instrument and readying it for rigorous evaluation and implementation in practice.</p>\",\"PeriodicalId\":8959,\"journal\":{\"name\":\"Bipolar Disorders\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bipolar Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/bdi.70037\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bipolar Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/bdi.70037","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Developing a Decision Support Tool to Guide Shared Decision-Making in Bipolar Depression Treatment: Results From a Collaboration Between Clinicians and People With Lived Experience.
Objective: To build consensus from different stakeholders on the content and digital interactivity of a shared decision making (SDM) tool to guide patient-clinician collaborative conversations about treatment for bipolar depression.
Patients and methods: This study was conducted between September 2022 and September 2023. In the first phase, we conducted a narrative review on pharmacological, neuromodulatory, and psychotherapeutic treatments available for bipolar depression. For each option, we assessed treatment effectiveness, side effects, need for clinical monitoring, clinical considerations, and cost. In the second phase, committees comprised of mental health clinicians and people with lived experience with bipolar disorder from a national mood disorders advocacy group identified key features and content to be included in the SDM tool. A thematic analysis of these data then contributed to populate the SDM tool.
Results: Twenty-one evidence-based treatment options identified from the narrative review were presented to the four convened committees (clinical, lived experience, peer council, and integrated steering committees) in five meetings. After discussions and thematic analysis, 12 outcomes of interest for each of the therapeutic interventions were delineated for inclusion in a web-based SDM tool. A detailed description of the development process and SDM tool is provided.
Conclusion: This is the first partnership between clinicians and persons with bipolar disorder lived experience charged with the development of a patient-centered SDM tool to integrate clinical evidence with real-world clinical practice and patient preferences for use during clinical encounters. Human-centered design and testing in real clinical encounters will now contribute to refining the instrument and readying it for rigorous evaluation and implementation in practice.
期刊介绍:
Bipolar Disorders is an international journal that publishes all research of relevance for the basic mechanisms, clinical aspects, or treatment of bipolar disorders and related illnesses. It intends to provide a single international outlet for new research in this area and covers research in the following areas:
biochemistry
physiology
neuropsychopharmacology
neuroanatomy
neuropathology
genetics
brain imaging
epidemiology
phenomenology
clinical aspects
and therapeutics of bipolar disorders
Bipolar Disorders also contains papers that form the development of new therapeutic strategies for these disorders as well as papers on the topics of schizoaffective disorders, and depressive disorders as these can be cyclic disorders with areas of overlap with bipolar disorders.
The journal will consider for publication submissions within the domain of: Perspectives, Research Articles, Correspondence, Clinical Corner, and Reflections. Within these there are a number of types of articles: invited editorials, debates, review articles, original articles, commentaries, letters to the editors, clinical conundrums, clinical curiosities, clinical care, and musings.